Amgen Aktie
WKN: 867900 / ISIN: US0311621009
| 13.12.2023 22:20:21 | 
FDA Grants Priority Review To Amgen's Application For Small Cell Lung Cancer Treatment
(RTTNews) - Amgen (AMGN) Wednesday announced that the Food and Drug Administration (FDA) has granted Priority Review for the company's Biologics License Application for tarlatamab.
Tarlatamab is a potential first-in-class, investigational delta-like ligand 3 targeting Bispecific T-cell Engager therapy for the treatment of adult patients with advanced small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.
"The FDA's Priority Review designation for this application underscores the urgency to provide new treatment options for patients with advanced SCLC who have progressed following treatment with platinum-based chemotherapy," said David M. Reese, M.D., executive vice president of Research and Development at Amgen. "While first-line treatments often show strong responses, patients can experience aggressive recurrences and long-term survival remains a challenge. Unfortunately, for patients who relapse, there are limited treatment options, emphasizing the importance of bringing new therapies to this patient population with advanced disease."
The FDA grants Priority Review to applications for medicines that offer, if approved, significant improvements over available options or may provide a treatment option where no adequate therapy currently exists.
 Der finanzen.at Ratgeber für Aktien!
						
						
						
							
								Der finanzen.at Ratgeber für Aktien!
							
							Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Amgen Inc.mehr Nachrichten
| 29.10.25 | Börse New York in Grün: Dow Jones legt am Mittwochmittag zu (finanzen.at) | |
| 27.10.25 | Starker Wochentag in New York: Dow Jones mit Zuschlägen (finanzen.at) | |
| 27.10.25 | Aufschläge in New York: Dow Jones liegt im Plus (finanzen.at) | |
| 27.10.25 | Dow Jones 30 Industrial-Papier Amgen-Aktie: So viel Gewinn hätte eine Amgen-Investition von vor 5 Jahren eingebracht (finanzen.at) | |
| 27.10.25 | Dow Jones aktuell: Dow Jones zeigt sich zum Start fester (finanzen.at) | |
| 27.10.25 | Freundlicher Handel: NASDAQ 100 präsentiert sich zum Start fester (finanzen.at) | |
| 24.10.25 | NYSE-Handel: Dow Jones zeigt sich zum Handelsstart fester (finanzen.at) | |
| 23.10.25 | Pluszeichen in New York: Dow Jones zum Ende des Donnerstagshandels mit Gewinnen (finanzen.at) |